EMEA (Europe, Middle East and Africa) Asthma Medication Market Report 2019

Table of Contents

EMEA (Europe, Middle East and Africa) Asthma Medication Market Report 2017
1 Asthma Medication Overview
1.1 Product Overview and Scope of Asthma Medication
1.2 Classification of Asthma Medication
1.2.1 EMEA Asthma Medication Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 EMEA Asthma Medication Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Quick-Relief Medications
1.2.4 Long-Term Control Medications
1.2.5 Asthma Medications During Pregnancy
1.3 EMEA Asthma Medication Market by Application/End Users
1.3.1 EMEA Asthma Medication Sales (Volume) and Market Share Comparison by Application (2012-2022
1.3.2 Children
1.3.3 Adolescent
1.3.4 Adult
1.4 EMEA Asthma Medication Market by Region
1.4.1 EMEA Asthma Medication Market Size (Value) Comparison by Region (2012-2022)
1.4.2 Europe Status and Prospect (2012-2022)
1.4.3 Middle East Status and Prospect (2012-2022)
1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Asthma Medication (2012-2022)
1.5.1 EMEA Asthma Medication Sales and Growth Rate (2012-2022)
1.5.2 EMEA Asthma Medication Revenue and Growth Rate (2012-2022)

2 EMEA Asthma Medication Competition by Manufacturers/Players/Suppliers, Region, Type and Application
2.1 EMEA Asthma Medication Market Competition by Players/Manufacturers
2.1.1 EMEA Asthma Medication Sales Volume and Market Share of Major Players (2012-2017)
2.1.2 EMEA Asthma Medication Revenue and Share by Players (2012-2017)
2.1.3 EMEA Asthma Medication Sale Price by Players (2012-2017)
2.2 EMEA Asthma Medication (Volume and Value) by Type/Product Category
2.2.1 EMEA Asthma Medication Sales and Market Share by Type (2012-2017)
2.2.2 EMEA Asthma Medication Revenue and Market Share by Type (2012-2017)
2.2.3 EMEA Asthma Medication Sale Price by Type (2012-2017)
2.3 EMEA Asthma Medication (Volume) by Application
2.4 EMEA Asthma Medication (Volume and Value) by Region
2.4.1 EMEA Asthma Medication Sales and Market Share by Region (2012-2017)
2.4.2 EMEA Asthma Medication Revenue and Market Share by Region (2012-2017)
2.4.3 EMEA Asthma Medication Sales Price by Region (2012-2017)

3 Europe Asthma Medication (Volume, Value and Sales Price), by Players, Countries, Type and Application
3.1 Europe Asthma Medication Sales and Value (2012-2017)
3.1.1 Europe Asthma Medication Sales Volume and Growth Rate (2012-2017)
3.1.2 Europe Asthma Medication Revenue and Growth Rate (2012-2017)
3.2 Europe Asthma Medication Sales and Market Share by Type
3.3 Europe Asthma Medication Sales and Market Share by Application
3.4 Europe Asthma Medication Sales Volume and Value (Revenue) by Countries
3.4.1 Europe Asthma Medication Sales Volume by Countries (2012-2017)
3.4.2 Europe Asthma Medication Revenue by Countries (2012-2017)
3.4.3 Germany Asthma Medication Sales and Growth Rate (2012-2017)
3.4.4 France Asthma Medication Sales and Growth Rate (2012-2017)
3.4.5 UK Asthma Medication Sales and Growth Rate (2012-2017)
3.4.6 Russia Asthma Medication Sales and Growth Rate (2012-2017)
3.4.7 Italy Asthma Medication Sales and Growth Rate (2012-2017)
3.4.8 Benelux Asthma Medication Sales and Growth Rate (2012-2017)

4 Middle East Asthma Medication (Volume, Value and Sales Price), by Region, Type and Application
4.1 Middle East Asthma Medication Sales and Value (2012-2017)
4.1.1 Middle East Asthma Medication Sales Volume and Growth Rate (2012-2017)
4.1.2 Middle East Asthma Medication Revenue and Growth Rate (2012-2017)
4.2 Middle East Asthma Medication Sales and Market Share by Type
4.3 Middle East Asthma Medication Sales and Market Share by Application
4.4 Middle East Asthma Medication Sales Volume and Value (Revenue) by Countries
4.4.1 Middle East Asthma Medication Sales Volume by Countries (2012-2017)
4.4.2 Middle East Asthma Medication Revenue by Countries (2012-2017)
4.4.3 Saudi Arabia Asthma Medication Sales and Growth Rate (2012-2017)
4.4.4 Israel Asthma Medication Sales and Growth Rate (2012-2017)
4.4.5 UAE Asthma Medication Sales and Growth Rate (2012-2017)
4.4.6 Iran Asthma Medication Sales and Growth Rate (2012-2017)

5 Africa Asthma Medication (Volume, Value and Sales Price) by Players, Countries, Type and Application
5.1 Africa Asthma Medication Sales and Value (2012-2017)
5.1.1 Africa Asthma Medication Sales Volume and Growth Rate (2012-2017)
5.1.2 Africa Asthma Medication Revenue and Growth Rate (2012-2017)
5.2 Africa Asthma Medication Sales and Market Share by Type
5.3 Africa Asthma Medication Sales and Market Share by Application
5.4 Africa Asthma Medication Sales Volume and Value (Revenue) by Countries
5.4.1 Africa Asthma Medication Sales Volume by Countries (2012-2017)
5.4.2 Africa Asthma Medication Revenue by Countries (2012-2017)
5.4.3 South Africa Asthma Medication Sales and Growth Rate (2012-2017)
5.4.4 Nigeria Asthma Medication Sales and Growth Rate (2012-2017)
5.4.5 Egypt Asthma Medication Sales and Growth Rate (2012-2017)
5.4.6 Algeria Asthma Medication Sales and Growth Rate (2012-2017)

6 EMEA Asthma Medication Manufacturers/Players Profiles and Sales Data
6.1 Dulera
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Asthma Medication Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Dulera Asthma Medication Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 QVAR
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Asthma Medication Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 QVAR Asthma Medication Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Glaxosmithkline plc
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Asthma Medication Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Glaxosmithkline plc Asthma Medication Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 MAP Pharmaceuticals，Inc
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Asthma Medication Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 MAP Pharmaceuticals，Inc Asthma Medication Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Merck & Co. Inc
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Asthma Medication Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Merck & Co. Inc Asthma Medication Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 AstraZeneca plc
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Asthma Medication Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 AstraZeneca plc Asthma Medication Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Roche Holdings Ltd
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Asthma Medication Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Roche Holdings Ltd Asthma Medication Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Genentech Inc
6.8.1 Company Basic Information, Manufacturing Base and Competitors
6.8.2 Asthma Medication Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Genentech Inc Asthma Medication Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Sepracor, Inc
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Asthma Medication Product Type, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Sepracor, Inc Asthma Medication Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Schering-Plough Corp
6.10.1 Company Basic Information, Manufacturing Base and Competitors
6.10.2 Asthma Medication Product Type, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Schering-Plough Corp Asthma Medication Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Sanofi-Aventis
6.12 Theravance Inc

7 Asthma Medication Manufacturing Cost Analysis
7.1 Asthma Medication Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Asthma Medication

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Asthma Medication Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Asthma Medication Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA Asthma Medication Market Forecast (2017-2022)
11.1 EMEA Asthma Medication Sales, Revenue and Price Forecast (2017-2022)
11.1.1 EMEA Asthma Medication Sales and Growth Rate Forecast (2017-2022)
11.1.2 EMEA Asthma Medication Revenue and Growth Rate Forecast (2017-2022)
11.1.3 EMEA Asthma Medication Price and Trend Forecast (2017-2022)
11.2 EMEA Asthma Medication Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Asthma Medication Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Asthma Medication Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Asthma Medication Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Asthma Medication Sales Forecast by Type (2017-2022)
11.7 EMEA Asthma Medication Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer



List of Tables and Figures

Figure Product Picture of Asthma Medication
Figure EMEA Asthma Medication Sales Volume (K Units) by Type (2012-2022)
Figure EMEA Asthma Medication Sales Volume Market Share by Type (Product Category) in 2016
Figure Quick-Relief Medications Product Picture
Figure Long-Term Control Medications Product Picture
Figure Asthma Medications During Pregnancy Product Picture
Figure EMEA Asthma Medication Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Asthma Medication by Application in 2016
Figure Children Examples
Table Key Downstream Customer in Children
Figure Adolescent Examples
Table Key Downstream Customer in Adolescent
Figure Adult Examples
Table Key Downstream Customer in Adult
Figure EMEA Asthma Medication Market Size (Million USD) by Region (2012-2022)
Figure Europe Asthma Medication Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Asthma Medication Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Asthma Medication Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Asthma Medication Revenue (Million USD) Status and Forecast by Countries
Figure Africa Asthma Medication Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Asthma Medication Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Asthma Medication Sales Volume and Growth Rate (2012-2022)
Figure EMEA Asthma Medication Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Asthma Medication Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA Asthma Medication Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA Asthma Medication Sales Share by Players (2012-2017)
Figure 2016 Asthma Medication Sales Share by Players
Figure 2017 Asthma Medication Sales Share by Players
Figure EMEA Asthma Medication Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Asthma Medication Revenue (Million USD) by Players (2012-2017)
Table EMEA Asthma Medication Revenue Share by Players (2012-2017)
Table 2016 EMEA Asthma Medication Revenue Share by Players
Table 2017 EMEA Asthma Medication Revenue Share by Players
Table EMEA Asthma Medication Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA Asthma Medication Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA Asthma Medication Sales Share by Type (2012-2017)
Figure Sales Market Share of Asthma Medication by Type (2012-2017)
Figure EMEA Asthma Medication Sales Market Share by Type (2012-2017)
Table EMEA Asthma Medication Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Asthma Medication Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Asthma Medication by Type in 2016
Table EMEA Asthma Medication Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA Asthma Medication Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA Asthma Medication Sales Share by Application (2012-2017)
Figure Sales Market Share of Asthma Medication by Application (2012-2017)
Figure EMEA Asthma Medication Sales Market Share by Application in 2016
Table EMEA Asthma Medication Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA Asthma Medication Sales Share by Region (2012-2017)
Figure Sales Market Share of Asthma Medication by Region (2012-2017)
Figure EMEA Asthma Medication Sales Market Share in 2016
Table EMEA Asthma Medication Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Asthma Medication Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Asthma Medication by Region (2012-2017)
Figure EMEA Asthma Medication Revenue Market Share Regions in 2016
Table EMEA Asthma Medication Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe Asthma Medication Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Asthma Medication Revenue and Growth Rate (2012-2017)
Table Europe Asthma Medication Sales (K Units) by Type (2012-2017)
Table Europe Asthma Medication Market Share by Type (2012-2017)
Figure Europe Asthma Medication Market Share by Type in 2016
Table Europe Asthma Medication Sales (K Units) by Application (2012-2017)
Table Europe Asthma Medication Market Share by Application (2012-2017)
Figure Europe Asthma Medication Market Share by Application in 2016
Table Europe Asthma Medication Sales (K Units) by Countries (2012-2017)
Table Europe Asthma Medication Sales Market Share by Countries (2012-2017)
Figure Europe Asthma Medication Sales Market Share by Countries (2012-2017)
Figure Europe Asthma Medication Sales Market Share by Countries in 2016
Table Europe Asthma Medication Revenue (Million USD) by Countries (2012-2017)
Table Europe Asthma Medication Revenue Market Share by Countries (2012-2017)
Figure Europe Asthma Medication Revenue Market Share by Countries (2012-2017)
Figure Europe Asthma Medication Revenue Market Share by Countries in 2016
Figure Germany Asthma Medication Sales (K Units) and Growth Rate (2012-2017)
Figure France Asthma Medication Sales (K Units) and Growth Rate (2012-2017)
Figure UK Asthma Medication Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Asthma Medication Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Asthma Medication Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Asthma Medication Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Asthma Medication Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Asthma Medication Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Asthma Medication Sales (K Units) by Type (2012-2017)
Table Middle East Asthma Medication Market Share by Type (2012-2017)
Figure Middle East Asthma Medication Market Share by Type (2012-2017)
Table Middle East Asthma Medication Sales (K Units) by Applications (2012-2017)
Table Middle East Asthma Medication Market Share by Applications (2012-2017)
Figure Middle East Asthma Medication Sales Market Share by Application in 2016
Table Middle East Asthma Medication Sales Volume (K Units) by Countries (2012-2017)
Table Middle East Asthma Medication Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Asthma Medication Sales Volume Market Share by Countries in 2016
Table Middle East Asthma Medication Revenue (Million USD) by Countries (2012-2017)
Table Middle East Asthma Medication Revenue Market Share by Countries (2012-2017)
Figure Middle East Asthma Medication Revenue Market Share by Countries (2012-2017)
Figure Middle East Asthma Medication Revenue Market Share by Countries in 2016
Figure Saudi Arabia Asthma Medication Sales (K Units) and Growth Rate (2012-2017)
Figure Israel Asthma Medication Sales (K Units) and Growth Rate (2012-2017)
Figure UAE Asthma Medication Sales (K Units) and Growth Rate (2012-2017)
Figure Iran Asthma Medication Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Asthma Medication Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Asthma Medication Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Asthma Medication Sales (K Units) by Type (2012-2017)
Table Africa Asthma Medication Sales Market Share by Type (2012-2017)
Figure Africa Asthma Medication Sales Market Share by Type (2012-2017)
Figure Africa Asthma Medication Sales Market Share by Type in 2016
Table Africa Asthma Medication Sales (K Units) by Application (2012-2017)
Table Africa Asthma Medication Sales Market Share by Application (2012-2017)
Figure Africa Asthma Medication Sales Market Share by Application (2012-2017)
Table Africa Asthma Medication Sales Volume (K Units) by Countries (2012-2017)
Table Africa Asthma Medication Sales Market Share by Countries (2012-2017)
Figure Africa Asthma Medication Sales Market Share by Countries (2012-2017)
Figure Africa Asthma Medication Sales Market Share by Countries in 2016
Table Africa Asthma Medication Revenue (Million USD) by Countries (2012-2017)
Table Africa Asthma Medication Revenue Market Share by Countries (2012-2017)
Figure Africa Asthma Medication Revenue Market Share by Countries (2012-2017)
Figure Africa Asthma Medication Revenue Market Share by Countries in 2016
Figure South Africa Asthma Medication Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria Asthma Medication Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt Asthma Medication Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria Asthma Medication Sales (K Units) and Growth Rate (2012-2017)
Table Dulera Asthma Medication Basic Information List
Table Dulera Asthma Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Dulera Asthma Medication Sales (K Units) and Growth Rate (2012-2017)
Figure Dulera Asthma Medication Sales Market Share in EMEA (2012-2017)
Figure Dulera Asthma Medication Revenue Market Share in EMEA (2012-2017)
Table QVAR Asthma Medication Basic Information List
Table QVAR Asthma Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure QVAR Asthma Medication Sales (K Units) and Growth Rate (2012-2017)
Figure QVAR Asthma Medication Sales Market Share in EMEA (2012-2017)
Figure QVAR Asthma Medication Revenue Market Share in EMEA (2012-2017)
Table Glaxosmithkline plc Asthma Medication Basic Information List
Table Glaxosmithkline plc Asthma Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Glaxosmithkline plc Asthma Medication Sales (K Units) and Growth Rate (2012-2017)
Figure Glaxosmithkline plc Asthma Medication Sales Market Share in EMEA (2012-2017)
Figure Glaxosmithkline plc Asthma Medication Revenue Market Share in EMEA (2012-2017)
Table MAP Pharmaceuticals，Inc Asthma Medication Basic Information List
Table MAP Pharmaceuticals，Inc Asthma Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure MAP Pharmaceuticals，Inc Asthma Medication Sales (K Units) and Growth Rate (2012-2017)
Figure MAP Pharmaceuticals，Inc Asthma Medication Sales Market Share in EMEA (2012-2017)
Figure MAP Pharmaceuticals，Inc Asthma Medication Revenue Market Share in EMEA (2012-2017)
Table Merck & Co. Inc Asthma Medication Basic Information List
Table Merck & Co. Inc Asthma Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck & Co. Inc Asthma Medication Sales (K Units) and Growth Rate (2012-2017)
Figure Merck & Co. Inc Asthma Medication Sales Market Share in EMEA (2012-2017)
Figure Merck & Co. Inc Asthma Medication Revenue Market Share in EMEA (2012-2017)
Table AstraZeneca plc Asthma Medication Basic Information List
Table AstraZeneca plc Asthma Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AstraZeneca plc Asthma Medication Sales (K Units) and Growth Rate (2012-2017)
Figure AstraZeneca plc Asthma Medication Sales Market Share in EMEA (2012-2017)
Figure AstraZeneca plc Asthma Medication Revenue Market Share in EMEA (2012-2017)
Table Roche Holdings Ltd Asthma Medication Basic Information List
Table Roche Holdings Ltd Asthma Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Roche Holdings Ltd Asthma Medication Sales (K Units) and Growth Rate (2012-2017)
Figure Roche Holdings Ltd Asthma Medication Sales Market Share in EMEA (2012-2017)
Figure Roche Holdings Ltd Asthma Medication Revenue Market Share in EMEA (2012-2017)
Table Genentech Inc Asthma Medication Basic Information List
Table Genentech Inc Asthma Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Genentech Inc Asthma Medication Sales (K Units) and Growth Rate (2012-2017)
Figure Genentech Inc Asthma Medication Sales Market Share in EMEA (2012-2017)
Figure Genentech Inc Asthma Medication Revenue Market Share in EMEA (2012-2017)
Table Sepracor, Inc Asthma Medication Basic Information List
Table Sepracor, Inc Asthma Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sepracor, Inc Asthma Medication Sales (K Units) and Growth Rate (2012-2017)
Figure Sepracor, Inc Asthma Medication Sales Market Share in EMEA (2012-2017)
Figure Sepracor, Inc Asthma Medication Revenue Market Share in EMEA (2012-2017)
Table Schering-Plough Corp Asthma Medication Basic Information List
Table Schering-Plough Corp Asthma Medication Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Schering-Plough Corp Asthma Medication Sales (K Units) and Growth Rate (2012-2017)
Figure Schering-Plough Corp Asthma Medication Sales Market Share in EMEA (2012-2017)
Figure Schering-Plough Corp Asthma Medication Revenue Market Share in EMEA (2012-2017)
Table Sanofi-Aventis Asthma Medication Basic Information List
Table Theravance Inc Asthma Medication Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Asthma Medication
Figure Manufacturing Process Analysis of Asthma Medication
Figure Asthma Medication Industrial Chain Analysis
Table Raw Materials Sources of Asthma Medication Major Manufacturers in 2016
Table Major Buyers of Asthma Medication
Table Distributors/Traders List
Figure EMEA Asthma Medication Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Asthma Medication Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Asthma Medication Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Asthma Medication Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA Asthma Medication Sales Market Share Forecast by Region (2017-2022)
Table EMEA Asthma Medication Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Asthma Medication Revenue Market Share Forecast by Region (2017-2022)
Table Europe Asthma Medication Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe Asthma Medication Sales Market Share Forecast by Countries (2017-2022)
Table Europe Asthma Medication Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Asthma Medication Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Asthma Medication Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East Asthma Medication Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Asthma Medication Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Asthma Medication Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Asthma Medication Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa Asthma Medication Sales Market Share Forecast by Countries (2017-2022)
Table Africa Asthma Medication Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Asthma Medication Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Asthma Medication Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA Asthma Medication Sales Market Share Forecast by Type (2017-2022)
Table EMEA Asthma Medication Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA Asthma Medication Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources